These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36661196)

  • 1. Efficacy of bortezomib desensitization among heart transplant candidates.
    Brinkley DM; Mangione M; Fossey SC; Harrison KM; Zalawadiya S; Rali AS; Siddiqi HK; Lindenfeld J; Schlendorf KH
    Clin Transplant; 2023 Apr; 37(4):e14907. PubMed ID: 36661196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does bortezomib influence pre-transplant desensitization therapy or benefit post-heart transplant outcomes for highly sensitized patients?
    Dhillon M; Kobashigawa JA; Kittleson M; Jain R; Patel N; Singer-Englar T; Zhang X; Hakimi M; Aintablian T; Vescio R; Dilibero D; Kransdorf E; Czer L; Nikolova AP; Patel JK
    Clin Transplant; 2024 Jan; 38(1):e15165. PubMed ID: 37837612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of anti-HLA antibodies in sensitized kidney transplant candidates subjected to desensitization with intravenous immunoglobulin and rituximab.
    Lobashevsky AL; Higgins NG; Rosner KM; Mujtaba MA; Goggins WC; Taber TE
    Transplantation; 2013 Jul; 96(2):182-90. PubMed ID: 23778648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is There a Role for Desensitization in Intestinal Transplantation?
    Santeusanio AD; Moon J; Nair V; Iyer KR
    Prog Transplant; 2019 Sep; 29(3):275-278. PubMed ID: 31170898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody desensitization therapy in highly sensitized lung transplant candidates.
    Snyder LD; Gray AL; Reynolds JM; Arepally GM; Bedoya A; Hartwig MG; Davis RD; Lopes KE; Wegner WE; Chen DF; Palmer SM
    Am J Transplant; 2014 Apr; 14(4):849-56. PubMed ID: 24666831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA desensitization with bortezomib in a highly sensitized pediatric patient.
    May LJ; Yeh J; Maeda K; Tyan DB; Chen S; Kaufman BD; Bernstein D; Rosenthal DN; Hollander SA
    Pediatr Transplant; 2014 Dec; 18(8):E280-2. PubMed ID: 25174602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA antibody profiling in thoracic transplantation undergoing desensitization therapy.
    Zeevi A; Lunz J
    Curr Opin Organ Transplant; 2012 Aug; 17(4):416-22. PubMed ID: 22790076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case Report: Successful Living Donor Kidney Transplantation in a Highly Human Leukocyte Antigen-Sensitized Recipient With a Positive Cytotoxic Crossmatch Using Bortezomib-Based Desensitization Without Intravenous Immunoglobulin.
    Revollo JY; Cuffy MC; Abu Jawdeh BG; Paterno F; Girnita A; Brailey P; Alloway RR; Woodle ES
    Transplant Proc; 2015 Sep; 47(7):2254-7. PubMed ID: 26361693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of carfilzomib-based desensitization on heart transplantation of sensitized candidates.
    Sriwattanakomen R; Xu Q; Demehin M; Shullo MA; Mangiola M; Hickey GW; Sciortino CM; Horn ET; Keebler ME; Zeevi A
    J Heart Lung Transplant; 2021 Jul; 40(7):595-603. PubMed ID: 33785250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overcoming the Immunological Barrier in Highly HLA Sensitized Renal Transplant Recipients - A Desensitization Experience from a Transplant Center in Pakistan.
    Mirza S; Mahmud SN; Abideen ZU; Aziz T; Akhter S; Baloch BK
    J Pak Med Assoc; 2019 Apr; 69(4):584-587. PubMed ID: 31000868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors Predicting Risk for Antibody-mediated Rejection and Graft Loss in Highly Human Leukocyte Antigen Sensitized Patients Transplanted After Desensitization.
    Vo AA; Sinha A; Haas M; Choi J; Mirocha J; Kahwaji J; Peng A; Villicana R; Jordan SC
    Transplantation; 2015 Jul; 99(7):1423-30. PubMed ID: 25606792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desensitization Using Bortezomib and High-dose Immunoglobulin Increases Rate of Deceased Donor Kidney Transplantation.
    Jeong JC; Jambaldorj E; Kwon HY; Kim MG; Im HJ; Jeon HJ; In JW; Han M; Koo TY; Chung J; Song EY; Ahn C; Yang J
    Medicine (Baltimore); 2016 Feb; 95(5):e2635. PubMed ID: 26844479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desensitization in kidney transplantation: review and future perspectives.
    Abu Jawdeh BG; Cuffy MC; Alloway RR; Shields AR; Woodle ES
    Clin Transplant; 2014 Apr; 28(4):494-507. PubMed ID: 24621089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful desensitization and kidney transplantation in the presence of donor-specific anti-human leukocyte antigen antibodies in kidney transplant recipients.
    Khan MT; Hamid RB; Sarfaraz S; Lal N; Ahmed J; Luxmi S
    Saudi J Kidney Dis Transpl; 2020; 31(6):1432-1438. PubMed ID: 33565460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desensitization protocols and their outcome.
    Marfo K; Lu A; Ling M; Akalin E
    Clin J Am Soc Nephrol; 2011 Apr; 6(4):922-36. PubMed ID: 21441131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly Sensitized Patients: Miami Transplant Institute Experience.
    Mattiazzi AD; Centeno A; Amador A; Fernandez-Bango C; Scowby CD; O'Rourke M; Hill-Matthie T; Patel R; Barrios F; Ruiz P; Chen L; Saghesima J; Ciancio G; Burke GW; Goldstein M; Chandar J; Contreras G; Roth D; Kupin W; Guerra G; Vianna R
    Clin Transpl; 2014; ():171-8. PubMed ID: 26281142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kidney transplant in highly sensitized patients after desensitization with plasmapheresis and low-dose intravenous immunoglobulin.
    Yuan XP; Wang CX; Gao W; Fu Q; He XS
    Exp Clin Transplant; 2010 Jun; 8(2):130-5. PubMed ID: 20565369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bortezomib in ABO-incompatible kidney transplant desensitization: a case report.
    Wong NL; O'Connell P; Chapman JR; Nankivell B; Kable K; Webster AC; Wong G
    Nephrology (Carlton); 2015 Mar; 20 Suppl 1():22-4. PubMed ID: 25807854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desensitization in heart transplant recipients: Who, when, and how.
    Shah KS; Patel J
    Clin Transplant; 2019 Aug; 33(8):e13639. PubMed ID: 31206862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of alloantibodies via proteasome inhibition in cardiac transplantation.
    Patel J; Everly M; Chang D; Kittleson M; Reed E; Kobashigawa J
    J Heart Lung Transplant; 2011 Dec; 30(12):1320-6. PubMed ID: 21968130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.